Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...

An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...

Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...

Trial underscores IROS's commitment to developing innovative therapies for unmet medical needs <li /> The study's success ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

Imagine having a digital carbon copy of yourself that physicians could use to predict long-term risks for disease, assess how your body may respond to treatment, and simulate surgeries in advance. A ...

Veeva share price has recently been battling concerns that Salesforce will become a more aggressive competitor and take ...

The gene neuropilin2 regulates inhibitory neuron migration and excitatory neuron connections, essential for balanced brain activity.

It’s more important to practice regularly than to sporadically do longer sessions. 20 minutes a day is a better bet than 60 ...

Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of ...

Tran Le was an engineering student at Stanford University when she tried to enroll in a clinical trial for her chronic ...